Omada Health
NASDAQ:OMDAMedical - Healthcare Information Services
+$0.13 today
- Market cap
- $817.04M
- Beta
- 2.09
- P/E (TTM)
- -162.6
- EPS (TTM)
- -$0.11
Volume 1.68M
Average 1.07M
OMDA EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Omada HealthNASDAQ: OMDA
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA remains negative
Q1 FY2026 EBITDA was -$1.44M, compared with -$7.04M a year earlier. Trailing-twelve-month EBITDA was $491K.
Context
- EBITDA amounted to 1.8% of revenue in FY2025, down 20.5 pp from a year earlier.
- EBITDA grew in size in 0 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 7 analysts of $46.86M (+1085.9%) for the fiscal year ending Dec 2026, a step up from the +87.4% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$1.44M-121.8% QoQ
- Last fiscal yearDec 2025
- -$4.75M+87.4% YoY
- LTMMar 2026
- $491K+101.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +79.5% | +340.1% | +260.6 pp |
| 1 year | +87.4% | +1085.9% | +998.5 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (4.75M) USD
- Year-over-year change
- +87.4%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (4.75M) | +87.4% |
| FY2024 | 2024-12-31 | (37.83M) | +35.2% |
| FY2023 | 2023-12-31 | (58.36M) | +8.8% |
| FY2022 | 2022-12-31 | (63.99M) | — |
EBITDA vs competitors
How OMDA compares with its peers on the latest reported figures
- OMDA's LTM Mar 2026 EBITDA of $491K is the 3rd highest of the 5 companies compared; the peer median is $2.15M.
- Its year-over-year change of +101.7% is the 2nd highest of 5, against a peer median of +65.8%.
- EBITDA amounts to 0.2% of revenue for OMDA, versus a peer median of 10.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $103.59M | +119.0% | — | 14.4% | |
| LTM Mar 2026 | $57.31M | +74.6% | — | 2.3% | |
| LTM Mar 2026 | $491K | +101.7% | — | 0.2% | |
| LTM Mar 2026 | -$53.01M | +56.9% | — | 22.3% | |
| LTM Sep 2026 | -$172.46M | -201.2% | — | 6.0% | |
| Peer median (excluding OMDA) | $2.15M | +65.8% | — | 10.2% | |
Competitors are the stored peer set for OMDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 89.19M | 122.78M | 169.8M | 260.21M |
| Cost of Revenue | 46.39M | 52.81M | 66.92M | 89.27M |
| Gross Profit | 42.79M | 69.97M | 102.88M | 170.94M |
| Gross Margin | 48.0% | 57.0% | 60.6% | 65.7% |
| Research & Development | 26.17M | 33.74M | 35.92M | 40.68M |
| Selling, General & Admin | 88.97M | 102.23M | 110.61M | 142.23M |
| Operating Expenses | 115.14M | 135.97M | 146.53M | 182.91M |
| Depreciation & Amortization | 4.33M | 4.45M | 4.8M | 5.49M |
| EBITDA | (63.99M) | (58.36M) | (37.83M) | (4.75M) |
| EBITDA Margin | -71.7% | -47.5% | -22.3% | -1.8% |
| Operating Income | (72.35M) | (66M) | (43.65M) | (11.97M) |
| Operating Margin | -81.1% | -53.8% | -25.7% | -4.6% |
| Interest Income | 2.2M | 5.78M | 805K | 5.31M |
| Interest Expense | 4.2M | 4.71M | 4.51M | 2.53M |
| Other Income / Expenses | (168K) | (1.51M) | (3.48M) | (806K) |
| Income Before Tax | (72.52M) | (67.51M) | (47.14M) | (12.78M) |
| Pre-Tax Margin | -81.3% | -55.0% | -27.8% | -4.9% |
| Income Tax Expense | 0 | 0 | 0 | 0 |
| Net Income | (72.52M) | (67.51M) | (47.14M) | (12.78M) |
| Net Margin | -81.3% | -55.0% | -27.8% | -4.9% |
| EPS (Basic) | (1.30) | (1.21) | (0.85) | (0.22) |
| EPS (Diluted) | (1.30) | (1.21) | (0.85) | (0.22) |
| Weighted Avg Shares | 55.74M | 55.74M | 55.74M | 58.43M |
| Weighted Avg Shares (Diluted) | 55.74M | 55.74M | 55.74M | 58.43M |
Omada Health
NASDAQ:OMDA
Intrinsic Alpha fair value
Locked
Current Price
$13.17
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.